Compare Becton Dickinson and Co (BDX) vs Goldman Sachs Group Inc (GS) Price & Performance

Becton Dickinson and CoTrade

Goldman Sachs Group IncTrade

Price performance (Past 24H)

Key statistics

Becton Dickinson and Co vs Goldman Sachs Group Inc — how do they compare? Becton Dickinson and Co trades at $180.75 (market cap $49.41B), while Goldman Sachs Group Inc trades at $1,037.49 (market cap $301.19B). The key difference: Goldman Sachs Group Inc is far larger — about 6.1× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays the higher dividend (2.32%). Which is the better fit depends on your goals.

	BDX	GS
Market Cap	$49.41B	$301.19B
Sector	Health	Financials
52-Week High	$185.39	$1.15K
52-Week Low	$138.62	$715.95
Enterprise Value	$65.51B	—
Dividend Yield	2.32%	1.93%
Volume	—	2,592,735

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Becton Dickinson and Co

No Aura AI signal available yet.

Goldman Sachs Group Inc

Goldman Sachs (GS) trades at $1,034.41, down 0.5% on the day, with a neutral technical signal. The company shows strong fundamental momentum with three consecutive quarterly EPS beats and revenue growth accelerating to $58.3B in 2025. Analyst consensus is mixed with 40% buy ratings but a $1,160 price target suggesting 12% upside potential. Recent news highlights Goldman's leadership role in major upcoming IPOs including Anthropic, SpaceX, and OpenAI.

The outlook remains positive given Goldman's positioning in the upcoming AI IPO wave and strong investment banking pipeline. Key risks include volatile cash flow patterns with negative operating cash flow in recent periods and market sensitivity to interest rate changes. The stock appears reasonably valued at 16x P/E with 31.7% net margins supporting further upside if earnings momentum continues.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BDX

BD completes enrollment in large trial testing Phasix™ Mesh to prevent incisional hernias after surgeryPRNewsWire · 4 hours agoBullish Two Dividend Aristocrats outperformed the market while two lagged; three new picks show promising dividend growth.24/7 Wall Street · 2 days agoNeutral View details →

Nvidia leads $500B Wall Street consortium to finance AI infrastructure expansion.24/7 Wall Street · 1 day agoBullish Wall Street giants plan $500B to finance AI infrastructure as a new asset class, says Nvidia CEO.CNBC · 1 day agoBullish Goldman Sachs advises investors to stay invested amid stable rates, AI benefits, and falling oil prices.CNBC · 1 day agoBullish View details →

About Becton Dickinson and Co

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

About Goldman Sachs Group Inc

The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.